Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
about
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malariaArtemisinin combination therapy for vivax malariaEpidemiology and Control of Plasmodium vivax in AfghanistanIn vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central EthiopiaResistance to therapies for infection by Plasmodium vivaxDihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.Defining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SPEfficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.Field trial of three different Plasmodium vivax-detecting rapid diagnostic tests with and without evaporative cool box storage in AfghanistanCost-effectiveness of malaria diagnosis using rapid diagnostic tests compared to microscopy or clinical symptoms alone in Afghanistan.Plasmodium vivax treatments: what are we looking for?Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities.Existing antimalarial agents and malaria-treatment strategies.Persistent detection of Plasmodium falciparum, P. malariae, P. ovale curtisi and P. ovale wallikeri after ACT treatment of asymptomatic Ghanaian school-children.Isolation and characterization of Pseudomonas sp. DX7 capable of degrading sulfadoxine.Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan.
P2860
Q24202910-1ABD988E-BF3C-4AE9-B500-B37D4AD7EFDAQ24622539-C5386217-7351-4E7E-8735-2C6AFF239E9CQ28355710-FD5D9198-DE46-427E-A153-AF4549E2789AQ28533253-2D80CD4F-634A-497A-8E31-D4276315FA3AQ33481576-AC47BF28-0697-4703-A9F2-BCD3C17FD71CQ33828657-B81A3592-196D-48CE-AE62-ECF4BF36661AQ34149975-19E678A0-FFCE-4E4F-B818-129D9B88715FQ34646141-54F40498-A8C4-4134-9B9B-83BC1C4586A1Q35121981-6F9424E8-12B3-4EFF-9475-FEE10258A0F1Q35669442-E7A25E3A-D7AC-40BF-92D5-22A730D827C1Q35760893-2E6BF981-A173-4E03-8A14-69CA1337C5E2Q37018626-9B12C754-0F9A-4AB0-A42A-6C5E168E8F65Q37492591-4060C44B-E8BB-431E-B51F-344C3E6ED1E4Q38973777-32693A8F-2A08-4EFB-91A5-4F8262618B38Q47995914-EFAC3835-569C-4B78-9DEA-7B3BD2E95FAEQ52651827-348D4AEA-9E47-434A-B9F2-7753EB6AE66B
P2860
Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Sulfadoxine-pyrimethamine plus ...... trial in eastern Afghanistan.
@en
type
label
Sulfadoxine-pyrimethamine plus ...... trial in eastern Afghanistan.
@en
prefLabel
Sulfadoxine-pyrimethamine plus ...... trial in eastern Afghanistan.
@en
P2093
P921
P1476
Sulfadoxine-pyrimethamine plus ...... trial in eastern Afghanistan.
@en
P2093
Kate Kolaczinski
Naeem Durrani
Sayed Rahim
P304
P356
10.1016/J.TRSTMH.2007.06.015
P50
P577
2007-08-17T00:00:00Z